Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Wolters Kluwer
  6. News
  7. Summary
    WKL   NL0000395903

WOLTERS KLUWER

(WKL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Wolters Kluwer : In India, Wolters Kluwer Provides Free Access To UpToDate Coronavirus Resources & Tools for Front-Line Clinicians & Medical Researchers

05/07/2021 | 09:31am EDT

India is witnessing an unprecedented rise in COVID-19 cases, creating enormous pressure on healthcare professionals and institutions in the country. More than ever before, clinicians are needed to make evidence-based decisions faster. For clinicians on the front lines of the COVID-19 pandemic who are seeking the most current, evidence-based content, all coronavirus topics in Wolters Kluwer’s UpToDate are available for free. Wolters Kluwer has also curated a list of novel coronavirus guidelines from global agencies such as CDC, ECDC, WHO and other public health organizations. UpToDate is an evidence-based clinical decision support (CDS) tool designed for healthcare professionals to provide clarity in decision-making while treating patients.

For final-year medical students and newly qualified doctors being mobilized to help with the shortage in medical staff, UpToDate’s most current coronavirus resources and tools are indispensable to get up to speed quickly on COVID-19 guidance and protocols. UpToDate can act as a trusted guide for the young medical workforce during their fight against the record COVID-19 surge in India.

“With a legacy of nearly 30 years, UpToDate has been there to support and promote the best patient care around the world, and we will never waver from that commitment,” said Denise Basow, MD, President and CEO, Clinical Effectiveness, Wolters Kluwer, Health. “With over 19 million views of our UpToDate COVID-19 topics in the last year, clinicians around the globe have relied heavily on Wolters Kluwer to care for their patients throughout the pandemic. It is paramount for healthcare professionals in India to access the information they so desperately need to treat patients during this latest crisis.”

Commenting on the current healthcare situation in India, Mr. Harish Ramachandran of Wolters Kluwer India said, “India is going through unfortunate times and healthcare professionals are in dire need of our support. Having direct access to UpToDate connects them with the latest medical evidence and treatment recommendations for COVID-19 patients.”

The global authors and contributors of UpToDate bring deep domain expertise on COVID-19 and collaborate with our physician editors and peer reviewers to deliver trustworthy evidence and recommendations that are rich in nuance, yet still clear and actionable. UpToDate delivers the evidence powered by clinical expertise from the world’s leading physicians for routine and complex cases of COVID-19.

To immediately access UpToDate clinical topics covering COVID-19 for free, please visit: https://www.wolterskluwer.com/en/solutions/uptodate/resources/covid-19

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.


© Business Wire 2021
All news about WOLTERS KLUWER
06/15WOLTERS KLUWER  : ELM Solutions expert to offer legal spend insights at 2021 Vir..
AQ
06/15New Future Ready Lawyer Survey from Wolters Kluwer Finds Trends and Technolog..
GL
06/14WOLTERS KLUWER  : Appoints New Chief Human Resources
MT
06/14WOLTERS KLUWER  : Novogene selects CCH Tagetik expert CPM solution from Wolters ..
AQ
06/14Wolters Kluwer appoints Bill Baker as Chief Human Resources Officer
GL
06/10WOLTERS KLUWER  : Compliance Solutions Wins Category Leader Honors in Chartis GR..
BU
06/10WOLTERS KLUWER  : Share Buyback Transaction Details June 3 – June 9, 2021
AQ
06/08WOLTERS KLUWER  : Launches Telemedicine Value Sets for Payers and Providers to T..
BU
06/07WOLTERS KLUWER  : global audit technology experts to present at the IIA 2021 Int..
BU
06/04WOLTERS KLUWER  : Compliance Solutions Earns Four American Business Awards
BU
More news
Financials
Sales 2021 4 648 M 5 640 M 5 640 M
Net income 2021 699 M 848 M 848 M
Net Debt 2021 2 117 M 2 568 M 2 568 M
P/E ratio 2021 30,4x
Yield 2021 1,71%
Capitalization 21 171 M 25 674 M 25 685 M
EV / Sales 2021 5,01x
EV / Sales 2022 4,78x
Nbr of Employees 18 785
Free-Float 98,1%
Chart WOLTERS KLUWER
Duration : Period :
Wolters Kluwer Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WOLTERS KLUWER
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Average target price 72,50 €
Last Close Price 81,44 €
Spread / Highest target 11,7%
Spread / Average Target -11,0%
Spread / Lowest Target -47,2%
EPS Revisions
Managers and Directors
NameTitle
Nancy McKinstry Chairman-Executive Board & Chief Executive Officer
Kevin B. Entricken Chief Financial Officer
Frans J. G. M. Cremers Chairman-Supervisory Board
Jeanette Horan Independent Member-Supervisory Board
Ann Elizabeth Ziegler Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
WOLTERS KLUWER17.93%25 674
S&P GLOBAL INC.20.47%95 480
RELX PLC7.59%51 926
THOMSON REUTERS CORPORATION14.73%48 813
MSCI INC.10.85%40 450
EQUIFAX INC.20.01%27 852